Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3334725)

Published in Crit Care on October 07, 2011

Authors

Fabienne Venet1, Alain Lepape, Guillaume Monneret

Author Affiliations

1: Hospices Civils de Lyon, Immunology Laboratory, Hôpital E, Herriot, 5 place d'Arsonval, 69437 Lyon cedex 03, France.

Articles cited by this

The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med (2006) 8.41

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19

Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med (2009) 4.98

Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol (2007) 4.56

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest (2009) 4.51

PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23

Immunotherapy for sepsis--a new approach against an ancient foe. N Engl J Med (2010) 3.62

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58

Pathophysiology of sepsis. Am J Pathol (2007) 3.19

Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol (2011) 3.12

Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med (2007) 2.88

Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med (2009) 2.65

Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med (2009) 2.39

Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34

Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med (2003) 2.32

Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med (2010) 2.31

IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol (2010) 2.29

Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods (2006) 2.14

The effects of injury on the adaptive immune response. Shock (1999) 2.07

Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96

Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med (2002) 1.80

Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78

Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem (2005) 1.74

A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol (2006) 1.50

Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48

Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics (2008) 1.32

Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock (2003) 1.25

Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun (2010) 1.25

Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection (2009) 1.21

Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med (2006) 1.19

Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med (2007) 1.18

Validation and quality control of immunophenotyping in clinical flow cytometry. J Immunol Methods (2000) 1.18

Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res (2004) 1.17

Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med (2009) 1.17

CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol (2009) 1.13

Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med (2009) 1.05

Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J Immunol Methods (2007) 1.03

Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol (2008) 1.02

Predictive values of neutrophil CD64 expression compared with interleukin-6 and C-reactive protein in early diagnosis of neonatal sepsis. J Clin Lab Anal (2010) 0.94

Interleukin-7 immunotherapy. Adv Exp Med Biol (2007) 0.92

Simultaneous determination of membrane CD64 and HLA-DR expression by blood neutrophils and monocytes using the monoclonal antibody fluorescence capability of a routine haematology analyser. J Immunol Methods (2006) 0.82

Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department. Pediatr Emerg Care (2008) 0.81

In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates. Cytokine (2002) 0.79

Comment on "IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis" and comment on "IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis". J Immunol (2010) 0.76

Articles by these authors

Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 5.00

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38

PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23

Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93

De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med (2014) 2.77

Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med (2006) 2.56

Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med (2004) 2.51

Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34

Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med (2003) 2.32

Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med (2010) 2.31

Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med (2005) 2.07

Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96

Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78

Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem (2005) 1.74

Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med (2009) 1.69

Decreased T-cell repertoire diversity in sepsis: a preliminary study. Crit Care Med (2013) 1.62

Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol (2011) 1.60

Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg (2004) 1.57

Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology (2002) 1.49

Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48

Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock. Crit Care Med (2011) 1.47

Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med (2015) 1.44

Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol (2006) 1.41

IL-7 restores lymphocyte functions in septic patients. J Immunol (2012) 1.39

Early assessment of leukocyte alterations at diagnosis of septic shock. Shock (2010) 1.37

The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett (2004) 1.37

Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett (2006) 1.36

Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother (2009) 1.30

The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy (2005) 1.28

Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock. Clin Chem (2002) 1.20

Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med (2005) 1.18

Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med (2007) 1.18

Consider delayed immunosuppression into the concept of sepsis. Crit Care Med (2008) 1.16

Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med (2012) 1.16

Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One (2012) 1.13

Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation. Crit Care (2013) 1.12

Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol (2013) 1.09

Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol (2008) 1.09

Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukoc Biol (2006) 1.09

Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis (2014) 1.07

Compliance with guidelines on antibiotic prophylaxis in total hip replacement surgery: results of a retrospective study of 416 patients in a teaching hospital. Infect Control Hosp Epidemiol (2004) 1.02

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med (2015) 0.98

Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors. J Crit Care (2007) 0.97

Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med (2010) 0.97

mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance. Crit Care (2011) 0.96

Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B Clin Cytom (2012) 0.96

Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care (2013) 0.94

Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol (2005) 0.93

Prevention of ventilator-associated pneumonia in intensive care units: an international online survey. Antimicrob Resist Infect Control (2013) 0.93

Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care (2010) 0.92

Family participation in care to the critically ill: opinions of families and staff. Intensive Care Med (2003) 0.92

Nosocomial infection after septic shock among intensive care unit patients. Infect Control Hosp Epidemiol (2008) 0.91

Immunotherapy - a potential new way forward in the treatment of sepsis. Crit Care (2013) 0.89

Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol (2010) 0.89

Percentage of regulatory T cells CD4+CD25+CD127- in HIV-infected patients is not reduced after cryopreservation. J Immunol Methods (2010) 0.88

CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects. Cytometry B Clin Cytom (2012) 0.87

Early-onset ventilator-associated pneumonia incidence in intensive care units: a surveillance-based study. BMC Infect Dis (2011) 0.87

Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach. Intensive Care Med Exp (2014) 0.85

Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies. Crit Care (2010) 0.85

Soluble human leukocyte antigen-G5 in septic shock: marked and persisting elevation as a predictor of survival. Crit Care Med (2007) 0.85

The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock. Clin Immunol (2004) 0.84

Decreased Monocyte HLA-DR Expression in Patients After Non-Shockable out-of-Hospital Cardiac Arrest. Shock (2016) 0.84

Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care (2011) 0.84

Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils. Intensive Care Med (2003) 0.84

Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Intensive Care Med (2014) 0.82

Metabolic phenotyping of traumatized patients reveals a susceptibility to sepsis. Anal Chem (2013) 0.82

Monocyte HLA-DR in sepsis: shall we stop following the flow? Crit Care (2014) 0.82

Fast renal trapping of porcine luteinizing hormone (pLH) shown by 123I-scintigraphic imaging in rats explains its short circulatory half-life. Reprod Biol Endocrinol (2003) 0.81

5-oxo-6,8,11,14-eicosatetraenoic acid stimulates the release of the eosinophil survival factor granulocyte/macrophage colony-stimulating factor from monocytes. J Biol Chem (2004) 0.81

High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever. Clin Infect Dis (2003) 0.81

A rapidly progressing lymphocyte exhaustion after severe sepsis. Crit Care (2012) 0.81

Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery. Bioconjug Chem (2013) 0.81

Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1. Clin Chem Lab Med (2010) 0.80

A dynamic view of mHLA-DR expression in management of severe septic patients. Crit Care (2011) 0.80